Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL
ClinicalTrials.gov study NCT02106091. IPD Sharing: Not stated. Countries: 4. Publications: 1.
VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT07346820. IPD Sharing: NO. Countries: 1. Publications: 8.
Systemic Inflammatory Markers in B-cell Neoplasm
ClinicalTrials.gov study NCT06847529. IPD Sharing: NO. Countries: 1. Publications: 14.
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
ClinicalTrials.gov study NCT05020392. IPD Sharing: NO. Countries: 1. Publications: 4.
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
ClinicalTrials.gov study NCT00003658. IPD Sharing: Not stated. Countries: 1. Publications: 2.
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL
ClinicalTrials.gov study NCT00709033. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors
ClinicalTrials.gov study NCT05388695. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma
ClinicalTrials.gov study NCT00001271. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell Leukemia
ClinicalTrials.gov study NCT02644655. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02405078. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02340936. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma
ClinicalTrials.gov study NCT07094477. IPD Sharing: NO. Countries: 1. Publications: 7.
Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas.
ClinicalTrials.gov study NCT07181785. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04676360. IPD Sharing: YES. Countries: 1. Publications: 0.
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05498220. IPD Sharing: NO. Countries: 1. Publications: 0.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM),
ClinicalTrials.gov study NCT00923507. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
ClinicalTrials.gov study NCT02576990. IPD Sharing: YES. Countries: 0. Publications: 3.
Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease
ClinicalTrials.gov study NCT02458014. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT07225439. IPD Sharing: NO. Countries: 1. Publications: 11.
Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04094142. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.